Skip to main content
Caplight Logo









Axorus

Axorus

Private
LoosHealthcare & Life Scienceshttps://axorus.com/

Last Round

Seed

Oct 2, 2020

Total Funding Raised

$2.36M

Company Overview

Axorus is a healthtech company that develops non-invasive photoacoustic contact lens technology to restore vision for patients with retinal blindness.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

retinal prosthesisvision restorationphotoacoustic neuromodulationbionic eyeneuro-electronic interfaceretinal degenerative diseasesmart glassesAge-Related Macular DegenerationAMDRetinitis PigmentosaRPnon-invasive medical devicebioelectronicsmedtechnear-infrared laser

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axorus Comparables

Compare Axorus with similar companies based on industry and business-model similarity.

Axorus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LambdaVision
77%
Bionic Vision Technologies
75%
Science Corporation
73%

Axorus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 2, 2020

Key People

Founding team and executive leadership

Hélène Moulet

Co-founder & CTO at Axorus

Founding Team

Jean-Damien Louise

CEO

Executive Team

Axorus Investors

Notable investors and investment history

Axorus investors
InvestorRounds
Happy CapitalSeed
Finovam GestionSeed
BpifranceSeed
SATT NordSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 44% MoM.

  • Oct 2, 2020

    $2.36M raised led by Finovam Gestion.

Axorus Filings

Explore SEC and related filing metadata, where available.

Axorus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Axorus's valuation, stock price, and market status.

Is Axorus a public or private company?

Axorus is a private company.

What is the current stock price of Axorus?

Axorus is a private company with no public stock price. Caplight tracks Axorus's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Axorus worth (valuation)?

Valuation information for Axorus is not publicly available.

Can I buy Axorus stock?

Axorus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Axorus's last funding round?

Axorus's most recent funding round was Seed on October 2, 2020.

Who are the main investors in Axorus?

Key investors in Axorus include Finovam Gestion.

Will Axorus IPO soon?

No public IPO plans have been announced for Axorus.

How can I track Axorus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axorus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLoos
Employee Range4
Year Founded2019
Last FundingOct 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?